TNS3 and neoplasm: We further investigated the role of TNS3 in vivo using subcutaneously xenograft tumor mice model and found that KYSE150 expressing shTNS3 (#2) significantly reduced the tumor volume and weight compared to shNC (Figure 5C, 5D).